Recruiting Hypertension Studies in Baltimore
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
The investigators' central hypothesis is that early combination therapy with two PAH-specific oral therapies that have been shown to be well tolerated in the pediatric population, sildenafil and bosen...
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
Randomized, triple-masked, parallel arm clinical trial of empagliflozin versus placebo in pulmonary arterial hypertension (PAH) participants on stable approved PAH-targeted medical therapy....
About Hypertension Clinical Trials in Baltimore
Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.
There are currently 2 hypertension clinical trials recruiting participants in Baltimore, MARYLAND. These studies are seeking a combined 178 participants. Research is being sponsored by Johns Hopkins University, Gustavo A Heresi, MD, MS. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hypertension Clinical Trials in Baltimore — FAQ
Are there hypertension clinical trials in Baltimore?
Yes, there are 2 hypertension clinical trials currently recruiting in Baltimore, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What hypertension treatments are being tested?
The 2 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov